If you prefer to listen rather than read, this blog is available as a podcast here. Or if you want to listen to just this post: Or download the MP3 A couple of months ago I had breakfast with one of my blog readers and frequent commenters, Mark. At the time he mentioned something interesting, which has been percolating in the back of my mind ever since. He said that medicines get approved by the FDA based on claims that they will accomplish some terminal good. Say, for example, lowering the number of deaths due to heart disease. On top of that they will also probably toss in a general reduction of related adverse health events, like heart attacks. But when they provide data to the FDA in support of these claims it won’t be data on deaths or heart attacks it will be data on how the medicine reduces LDL cholesterol levels.
The Cholesterol of a Healthy Society
The Cholesterol of a Healthy Society
The Cholesterol of a Healthy Society
If you prefer to listen rather than read, this blog is available as a podcast here. Or if you want to listen to just this post: Or download the MP3 A couple of months ago I had breakfast with one of my blog readers and frequent commenters, Mark. At the time he mentioned something interesting, which has been percolating in the back of my mind ever since. He said that medicines get approved by the FDA based on claims that they will accomplish some terminal good. Say, for example, lowering the number of deaths due to heart disease. On top of that they will also probably toss in a general reduction of related adverse health events, like heart attacks. But when they provide data to the FDA in support of these claims it won’t be data on deaths or heart attacks it will be data on how the medicine reduces LDL cholesterol levels.